Back
ProShares Ultra Gold Vs. SpringWorks Therapeutics Industry Stock Comparison
Sell
47
UGL
ProShares Ultra Gold
Last Price:
$115.48
Seasonality Move:
0.39%
Sell
11
SWTX
SpringWorks Therapeutics
Last Price:
$36.97
Seasonality Move:
5.59%
Sell
47
ProShares Ultra Gold (UGL)
is a Sell
Is ProShares Ultra Gold a Buy, Sell or Hold?
-
The current ProShares Ultra Gold [UGL] share price is $115.42. The Score for UGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
UGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
UGL Stock Price Chart
What is ProShares Ultra Gold's stock price today?
-
The ProShares Ultra Gold share price today is $115.42The current trend is moderately bearish and UGL is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $36.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.
UGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.67 | Buy |
Relative Strength Index (14 RSI): | 42.91 | Sell |
Chaikin Money Flow: | -486708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.92 - 125.02) | Sell |
Bollinger Bands (100): | (94.35 - 116.09) | Buy |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.41 | Sell |
Relative Strength Index (14 RSI): | 31.76 | Sell |
Chaikin Money Flow: | -1228444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.93 - 51.91) | Sell |
Bollinger Bands (100): | (35.17 - 50.17) | Sell |
UGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 124.75 | Sell |
20-day SMA: | 121.32 | Sell |
50-day SMA: | 114.66 | Buy |
200-day SMA: | 97.2 | Buy |
8-day EMA: | 122.53 | Sell |
20-day EMA: | 120.96 | Sell |
50-day EMA: | 115.08 | Buy |
200-day EMA: | 98.97 | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.32 | Sell |
20-day SMA: | 47.1 | Sell |
50-day SMA: | 47.64 | Sell |
200-day SMA: | 39.14 | Sell |
8-day EMA: | 42.51 | Sell |
20-day EMA: | 45.83 | Sell |
50-day EMA: | 46.19 | Sell |
200-day EMA: | 41.19 | Sell |
ProShares Ultra Gold Earnings Growth & UGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
ProShares Ultra Gold Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |